Defining RNA oligonucleotides that reverse deleterious phase transitions of RNA-binding proteins with prion-like domains

Lin Guo(Thomas Jefferson University), James Shorter(University of Pennsylvania), Emma Robinson(Thomas Jefferson University), Alessandra Chesi(Stanford University), Bo Lim Lee(University of Pennsylvania), Amanda M. Gleixner(University of Pittsburgh), Hejia Wang(Bloomberg (United States)), Ellen Lavorando(University of Pennsylvania), Ashleigh Smirnov(University of Pennsylvania), Christopher J. Donnelly(University of Pittsburgh), Jacob R. Mann(University of Pittsburgh), Carolann Espy(Translational Therapeutics (United States)), Eric J. Huang(Broad Center), Yulei Shang(Broad Center), Tapas Paul(Johns Hopkins University), Hana M. Odeh(University of Pennsylvania), JiaBei Lin(University of Pennsylvania), Bede Portz(University of Pennsylvania), George M. Padilla(University of Pennsylvania), Sua Myong(Boston Children's Hospital), Nicolas L. Fawzi(Brown University), Laura R. Ganser(Johns Hopkins University), Jocelyn C. Mauna(University of Pittsburgh), Zamia Diaz(University of Pennsylvania), Kevin M. Kim(Thomas Jefferson University), Jenny L. Carey(Thomas Jefferson University), Katie E. Copley(University of Pennsylvania), Anastasia C. Murthy(Brown University), Jack D. Rubien(University of Pennsylvania)
bioRxiv (Cold Spring Harbor Laboratory)
September 4, 2023
Cited by 14


Related Papers